wxk001

Walter K. Kraft, MD

Contact Dr. Kraft

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-9077
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
  2. Buprenorphine in Neonatal Abstinence Syndrome
  3. The Impact of a Transition of Care Program on Acute Myocardial Infarction Readmission Rates
  4. The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome
  5. Medication Complications in Extracorporeal Membrane Oxygenation
  6. The authors reply
  7. The Nephrotoxicity of Vancomycin
  8. Tumor necrosis factor inhibitors in psoriatic arthritis
  9. Buprenorphine for the treatment of the neonatal abstinence syndrome
  10. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  11. A population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy
  12. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: A cohort study
  13. Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects
  14. Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers
  15. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant
  16. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  17. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome
  18. Pharmacologic and clinical evaluation of posaconazole
  19. Ethanol Pharmacokinetics in Neonates and Infants
  20. Current Therapeutic Research is Now Indexed on PubMed